Experienced in Mitochondrial Complex 1 Deficiency

Jing D. Peng

No.160 Pujian Road, 
Shanghai, CN 
Experienced in Mitochondrial Complex 1 Deficiency
No.160 Pujian Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Jing Peng practices in Shanghai, China. Ms. Peng is rated as an Experienced expert by MediFind in the treatment of Mitochondrial Complex 1 Deficiency. Her top areas of expertise are Epilepsy, Spasmus Nutans, West Syndrome, Synovectomy, and Endoscopy.

Her clinical research consists of co-authoring 1001 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Mitochondrial Complex 1 Deficiency.

Gender
Female

Locations

No.160 Pujian Road, Shanghai, 200127, China
Other Locations
Hainan Branch, Sanya, China
87 Xiangya Road, Changsha, 410008, China
No. 519 Kunzhou Road, Kunming, 650118, China
19 Yuquan Road, Yuquan, 100049, China
Wenhua Road 103, Shenyang, 110016, China
No. 74 Zhongshan Road 2, Guangzhou, 510080, China
No. 2898 Jin Bei Road, Zhangguizhuang, China
320 XunYang East Road, Jiujiang, 332000, China
264 MinDe Road, Nanchang, 330006, China
No. 1630 Dongfang Road, Dongfang, 200127, China
74 Zhongshan 2nd Rd, Guangzhou, 510080, China
Luoshi Road 122, Wuhan, China
196 West Huayang Road, Yangzhou, China
87 Xiangya Road, Changsha, China
No.24 Block 1, Xuefu Road, Chengdu, 610225, China
Fuxing 28# Road, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
View 2 Less Clinical Trials

1001 Total Publications

Resective Surgery for Drug-Resistant Epilepsy in Patients With Tuberous Sclerosis Complex: A Prospective Nationwide Multicenter Cohort Study.
Resective Surgery for Drug-Resistant Epilepsy in Patients With Tuberous Sclerosis Complex: A Prospective Nationwide Multicenter Cohort Study.
Journal: Neurology
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Peng's expertise for a condition
ConditionClose
    View All 28 Advanced Conditions
    View All 188 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile